Treanda maker gets SEC subpoena

Submitted by Ross Bonander Tue 09/27/2011

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

According to the pharmaceutical blog Pharmalot, Cephalon, the company that makes Treanda (bendamustine) has become the subject of a Securities and Exchange Commission investigation into possible marketing of the drug in unapproved indications.

Cephalon is already functioning under a Corporate Integrity Agreement after the Justice Department busted them in 2008 for marketing several medications for unapproved indications. Cephalon also paid a few hundred million dollars in fines.

Treanda is currently approved in the treatment of:

- Patients with indolent B-cell non-Hodgkin lymphoma (NHL) that progressed during or within six months of treatment with Rituxan or a Rituxan-containing regimen.
- Patients with chronic lymphocytic leukemia (CLL).

While doctors are free to use drugs off-label, a pharmaceutical company can only market a drug under its approved indications.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.